Spanish
Santo Domingo. - Grupo González Pittaluga, owner of Amadita Laboratorio Clínico, a leading company in health and diagnostics in the Dominican Republic, announced today the acquisition of 100% of Centrimed, a renowned provider of imaging services and medical solutions.
This strategic acquisition strengthens the position of the González Pittaluga Group as a national leader in health innovation, expanding its portfolio of diagnostic and clinical services, and reaffirming its commitment to patient-centered care.
"With this acquisition, the Group reaffirms its mission to be a benchmark for innovation and trust, working every day to offer health solutions that positively impact people's quality of life," highlighted Dr. Patricia González Pittaluga, president of Grupo González Pittaluga.
You can also read: KLEVERPLAST boosts local production of plastic meshes with a sustainable approach
For his part, the president of Amadita Laboratorio Clínico, Alberto Bergés González, highlighted that the incorporation of Centrimed "represents a significant milestone in the expansion and growth strategy of the business group and Amadita." Similarly, Giancarlo Sanguinetti Durand, CEO of Amadita Laboratorio Clínico, stated that "by adding the solid technical experience and resources of Centrimed, we are better positioned to offer high-quality and accessible health solutions to communities throughout the country." With this acquisition, Amadita Laboratorio Clínico: It will expand its offer of specialized diagnostic services and medical technology. It will expand its reach to new patient segments and geographic areas. It will invest in innovation and digital transformation to improve accessibility and efficiency. Dr. Pedro Pablo Díaz, founder of Centrimed and who will continue to collaborate and contribute his vast technical and scientific knowledge, expressed his optimism about the future of the institution: “I am satisfied and confident of this new stage with the González Pittaluga Group with whom we share similar values and principles. The main reason why we have given our vote of confidence for the future of Centrimed.”
